Belgium · Biotechnology startup
Belgium · Rewind Therapeutics
Rewind Therapeutics is a Belgium-based biotechnology company that researches and develops remyelinating therapies for the treatment of multiple sclerosis.
Funding reportedLast round: Series A
What company datasets say Rewind Therapeutics raised
Funding, as reported
Reported in all18.1Min the source's currency
Rounds3
Last roundSeries A
Last round dateJan 2023
Investors listed7
The company, in detail
What they build
Built with from their website
Google MapsWordPress.orgFont AwesomeMax Mega MenuViewport MetaGoogle Maps PlatformPriority HintsGoogle Font APIimagesLoadedMicrosoft Exchange
+8 more
MySQLPrimeNGwpBakeryMicrosoft 365 Apps & ServicesMobile FriendlyjQueryRSSIonicons
- Sector
- Biotechnology
- Region
- Flanders
- Revenue
- 3.1M a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in Belgium
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Rewind Therapeutics in front of investors. Or tell us what we have wrong.